Canopy Growth Corporation - Common Shares (CGC)

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

U.S. stock futures dropped on Tuesday following Friday's negative moves. Futures of major benchmark indices were trading lower.

U.S. stock futures lower on Tuesday. Nio, Hyperscale Data, Signet Jewelers, Canopy Growth, and Zscaler expected to report earnings.

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.

Tilray shares rose ~5% after launching three EU-GMP medical cannabis strains in Germany and confirming renewed Nasdaq bid-price compliance.

Cannabis stocks and ETFs skyrocketed after Trump hinted at reclassifying marijuana. Tilray surged 35% in 2 days. Other top performers included Trulieve, Tilray, Curaleaf, and Canopy Growth. This shift could ease federal regulations and improve the industry's growth potential.

Tilray stock surged 14.13% after hours as reports of a possible marijuana reclassification by Trump fueled investor optimism.

Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that President Trump is considering reclassifying marijuana as a less dangerous drug.

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Canopy Growth reported higher-than-expected Q1 revenue fueled by cannabis sales, but margins narrowed and earnings missed analyst expectations.